Dr. Stephanie Bustros, MD

Dr. Bustros practices at University Hospital (MU Health Care) in Columbia, Missouri.

Dr. Bustros' NPI, 1316467756, was assigned on June 27, 2017. Dr. Bustros holds Missouri license 2022049679.

Dr. Bustros' primary practice is University Hospital (MU Health Care), at 1 Hospital Dr, Columbia, MO 65201 in Boone County. The practice phone is (573) 882-4141.

Dr. Bustros' primary practice is University Hospital (MU Health Care) in Columbia, Missouri. Dr. Bustros is also affiliated with University Hospital. The medical group on file is University of Missouri Health Care. Dmand AI also links Dr. Bustros to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bustros practices, 4 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Bustros' primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Bustros is licensed in Missouri.

CMS data shows 447 Medicare services from Dr. Bustros across 9 procedure codes in 2024, for 230 Medicare patients. Medicare paid $32,661 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 230 Medicare patients who saw Dr. Bustros in 2024. The largest group is 65 to 74, with 80 patients. 74% of them have high blood pressure, and 58% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bustros' median patient age at 65, with 55% women.

In 2024, Dr. Bustros wrote 873 Medicare Part D claims for 106 patients. 79% of them were for generic drugs. CMS names the drug for 746 of them, across 22 drugs with 11 or more claims each, at $333,030 in total drug cost. In 2020, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Bustros for performance year 2024, reported as part of a group. Dr. Bustros accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bustros as offering telehealth.

CMS Open Payments shows 23 general payments to Dr. Bustros from 4 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 51% of the total. Neuropace, Inc. paid the most, $1,608.